Try our Advanced Search for more refined results
Health
-
February 09, 2026
Paul Weiss, Goodwin Steer Eli Lilly's $2.4B Orna Buy
Pharmaceutical giant Eli Lilly & Co., advised by Paul Weiss Rifkind Wharton & Garrison LLP, on Monday announced that it has agreed to buy Goodwin Procter LLP-led biotechnology firm Orna Therapeutics Inc. in a deal where Orna shareholders could receive up to $2.4 billion in cash.
-
February 09, 2026
Safanad Sells UK Care Home Biz To REIT For $1.6B
Principal-led investment company Safanad announced Monday that it sold U.K. care-home provider HC-One to a healthcare real estate investment trust for over $1.6 billion.
-
February 06, 2026
Ga. Panel Backs Sperm Bank Win In 'Wrongful Birth' Case
A Georgia appeals court backed a win for sperm bank Xytex Corp. in consolidated litigation alleging the company sold sperm under false pretenses about the medical, psychological and social history of the donors.
-
February 06, 2026
HHS Refers Hims & Hers To DOJ Amid Compound Drug Fight
U.S. Department of Health and Human Services general counsel Mike Stuart announced Friday that his office referred Hims & Hers Health Inc. to the U.S. Department of Justice for investigation, a day after Novo Nordisk A/S threatened litigation over what it called the telehealth company's "knockoff" version of its popular weight loss drug Wegovy.
-
February 06, 2026
'Very Bizarre': Trump's Funding Freeze Appeal Vexes DC Circ.
D.C. Circuit judges struggled Friday with whether to unblock a federal funding freeze carrying multitrillion-dollar implications, as a Trump administration lawyer disclaimed interest in a vast spending halt but also dodged opportunities to rule it out unequivocally.
-
February 06, 2026
11th Circ. OKs Immunity Denial In Fla. Excessive Force Case
The Eleventh Circuit ruled Friday that two Florida police officers named in a civil lawsuit should not be granted qualified immunity for their conduct during a Baker Act arrest of a person they knew to be mentally unwell.
-
February 06, 2026
NJ Judge Tosses Pacira Investor Suit Over Patent Loss
A New Jersey federal judge on Friday threw out an investor lawsuit against Pacira BioSciences Inc. after a court invalidated a patent for its key pain management drug, ruling that the pharmaceutical company was not required to disclose litigation setbacks it encountered before the final ruling.
-
February 06, 2026
Contractor Says VA's Uber Deal Is Taking Away Driving Biz
The U.S. Department of Veterans Affairs violated the law when it awarded contracts to Uber and Onward Health to transport patients in San Francisco because the process was not transparent, the owner of a small transportation company alleged in a federal claims court suit.
-
February 06, 2026
Colo. Nonprofit Drops Suit Over Medicaid Therapy Cuts
A Colorado healthcare nonprofit Thursday voluntarily dismissed its complaint seeking to reverse an allegedly unlawful executive order signed by Gov. Jared Polis that cut state Medicaid spending to pediatric behavioral therapy and autism therapy services.
-
February 06, 2026
Arizona Abortion Restrictions Found Unconstitutional
An Arizona state court permanently struck down a slew of restrictions on abortion care in the state, including an ultrasound mandate and a ban on the mailing of abortion pills, finding that the restrictions violate the right to abortion enshrined in the state's constitution.
-
February 06, 2026
PTAB Tosses 2nd Patent On Cologuard Colon Cancer Test
The Patent Trial and Appeal Board has found that Geneoscopy had shown that all the claims it challenged in a patent on Exact Sciences' colon cancer test Cologuard are invalid as obvious, months after the PTAB invalidated claims in a similar patent.
-
February 06, 2026
3rd Circ. Remands J&J Unit's Libel Suit Over Talc Study
Johnson & Johnson's talc liability unit will get another chance to pursue libel claims against a scientist over an article she wrote linking talcum power to mesothelioma, after the Third Circuit agreed to send the case back to New Jersey federal court.
-
February 06, 2026
Ex-Yale New Haven Hospital Exec Drops Covenant Payment Suit
A Connecticut federal judge has accepted a deal to dismiss a lawsuit claiming Yale New Haven Hospital withheld $994,000 in contractually required payments to its former chief operating officer, but said the parties can reopen the dispute if they need the court's intervention.
-
February 06, 2026
Ex-President Accuses Physician AI Co. Of Fraud, Wage Theft
A data science platform and its top brass persuaded its former chief strategy officer and president to invest $750,000 in the business, only then to not pay him wages, the former employee told a North Carolina federal court, claiming he's owed more than $430,000 in commission wages.
-
February 06, 2026
NJ Watchdog Must Give Up Files In Hospital Row
A New Jersey federal judge has refused to disturb a magistrate judge's decision compelling a state watchdog to turn over documents from its inquiry into CarePoint Health Systems Inc., rejecting the agency's bid to shield its files with grand-jury-like secrecy and reaffirming that federal privilege law governs discovery disputes in federal court.
-
February 06, 2026
2nd Circ. Affirms Nix Of NY Anesthesiologists' Antitrust Suit
A New York anesthesiology practice didn't sustain an antitrust injury when a UnitedHealthcare unit used its market power to cut reimbursement rates, a Second Circuit panel affirmed Friday, finding that the change in rates was a natural consequence of the health insurance system and doesn't equate to anticompetitive harm.
-
February 06, 2026
Hospital Pays $595K To End Ex-Workers' Retirement Suit
A Cambridge hospital system agreed to pay $595,000 to settle a proposed class action claiming it mismanaged its $280 million retirement plan and cost workers millions in savings by failing to reduce management fees and trim costly funds from the plan, according to a Massachusetts federal court filing.
-
February 06, 2026
Anti-Pot Advocates Vow To Fight Legalization In Courts
Principals and allies of a leading antidrug nonprofit pledged Friday to pursue the fight against marijuana legalization and normalization in the courts by challenging a pending proposal to loosen federal cannabis restrictions and directly suing some of the country's largest marijuana companies.
-
February 06, 2026
Taxation With Representation: Gibson Dunn, S&C, Wachtell
In this week's Taxation With Representation, Elon Musk announces SpaceX's acquisition of his artificial intelligence company xAI, Devon Energy and Coterra Energy agree to merge, and Banco Santander SA acquires Webster Financial Corp.
-
February 06, 2026
Mangione's NY State Trial Set for June, Before Feds' Case
A New York state court judge said Friday that Luigi Mangione's state murder charges will go to trial this summer ahead of his federal case, waving off concerns from defense counsel about the difficulty of trying the state case three months before a federal trial.
-
February 06, 2026
HHS Ends 340B Drug Rebate Pilot After Legal Challenge
The U.S. Department of Health and Human Services has ended a proposed rebate program that would have altered how hospitals receive payments for participating in the federal 340B drug discount program, which provides discounted prescription drugs for low-income Americans, after facing a lawsuit from a major hospital association.
-
February 05, 2026
Philly Judge Erred In Bumping Med Mal Suit To NJ, Panel Says
The Pennsylvania Superior Court has ruled in a precedential opinion that a Philadelphia judge incorrectly handed Rothman Orthopaedics a win by agreeing that a woman's medical malpractice suit against it should have been filed in New Jersey, reasoning that the company failed to show "weighty" reasons that the city was not the right place to litigate the case.
-
February 05, 2026
Meta Must Redo User Engagement Data In Mental Health MDL
A California federal judge overseeing discovery in litigation against social media giants over their effect on youth mental health ordered Meta to provide plaintiffs with updated data on the amount of time users spend on Instagram and Facebook, after state attorneys general argued Meta had skewed the times downward.
-
February 05, 2026
NYAG's Insider Trading Case A Power Grab, Judge Told
The former CEO of healthcare contractor Emergent BioSolutions Inc. has removed to federal court New York Attorney General Letitia James' insider trading case against him, alleging James is trying to expand her office's power through claims that concern questions of federal law.
-
February 05, 2026
Wash. Lawyer Faces Sanction Threat Over Alleged AI Errors
A federal judge has ordered an attorney in Washington state to submit a sworn declaration explaining why she shouldn't be sanctioned for what opposing counsel claimed are dozens of artificial intelligence "hallucinations" across multiple case filings.
Expert Analysis
-
Series
The Law Firm Merger Diaries: Forming Measurable Ties
Relationship-building should begin as early as possible in a law firm merger, as intentional pathways to bringing people together drive collaboration, positive client response, engagements and growth, says Amie Colby at Troutman.
-
AG Watch: Va. Insulin Price Probe Signals Rising Scrutiny
Virginia Attorney General Jason Miyares' recent investigation into insulin manufacturers and pharmacy benefit managers for allegedly colluding to artificially inflate insulin prices reflects a broader trend to leverage consumer protection authority in high-impact healthcare matters, and the upcoming leadership change is unlikely to diminish scrutiny in this area, says Chuck Slemp at Cozen O'Connor.
-
Opinion
US Cybersecurity Strategy Must Include Immigration Reform
Cyberthreats are escalating while the cybersecurity workforce remains constrained due to a lack of clear standards for national-interest determinations, processing backlogs affecting professionals who protect critical public systems and visa allocations that do not reflect real-world demands, says Rusten Hurd at Colombo & Hurd.
-
3 Key Takeaways From Planned Rescheduling Of Cannabis
An executive order reviving cannabis rescheduling represents a monumental change for the industry and, while the substance will remain illegal at the federal level, introduces several benefits, including improving state-legal cannabis operators' tax treatment, lowering the industry's legal risk profile, and leaving state-regulated markets largely intact, say attorneys at Dentons.
-
6 Issues That May Follow The 340B Rebate Pilot Challenge
Though the Health Resources and Services Administration withdrew a pending case to reconsider the controversial 340B rebate pilot program, a number of crucial considerations remain, including the likelihood of a rework and questions about what that rework might look like, say attorneys at Spencer Fane.
-
5 E-Discovery Predictions For 2026 And Beyond
2026 will likely be shaped by issues ranging from artificial intelligence regulatory turbulence to potential evidence rule changes, and e-discovery professionals will need to understand how to effectively guide the responsible and defensible adoption of emerging tools, while also ensuring effective safeguards, say attorneys at Littler.
-
2026 State AI Bills That Could Expand Liability, Insurance Risk
State bills legislating artificial intelligence that are expected to pass in 2026 will reshape the liability landscape for all companies incorporating AI solutions into their business operations, as any novel private rights of action authorized under AI-related statutes signal expanding exposures, say attorneys at Wiley.
-
Business Considerations Amid Hemp Product Policy Change
With the passage of a bill fundamentally narrowing the federal definition of "hemp," there are practical and business considerations that brands, manufacturers and other parties should heed over the next year, including operational strategies, evaluating contract and counterparty risk, and tax implications, say attorneys at Foley Hoag.
-
Series
Judges On AI: How Courts Can Boost Access To Justice
Arizona Court of Appeals Judge Samuel A. Thumma writes that generative artificial intelligence tools offer a profound opportunity to enhance access to justice and engender public confidence in courts’ use of technology, and judges can seize this opportunity in five key ways.
-
Opinion
DHS' Parole Termination Violates APA And Due Process
The U.S. Department of Homeland Security’s abrupt termination of family reunification parole programs violates both the Administrative Procedure Act and the due process rights of vetted beneficiaries who relied on the government's explicit invitation to wait in the U.S. for an immigrant visa to become available, says Abdoul Konare at Konare Law.
-
2025's Most Notable State AG Activity By The Numbers
State attorneys general were active in 2025, working across party lines to address federal regulatory gaps in artificial intelligence, take action on consumer protection issues, continue antitrust enforcement and announce large settlements on behalf of their citizens, say attorneys at Jenner & Block.
-
Opinion
The Case For Emulating, Not Dividing, The Ninth Circuit
Champions for improved judicial administration should reject the unfounded criticisms driving recent Senate proposals to divide the Ninth Circuit and instead seek to replicate the court's unique strengths and successes, says Ninth Circuit Judge J. Clifford Wallace.
-
How 11th Circ.'s Zafirov Decision Could Upend Qui Tam Cases
Oral argument before the Eleventh Circuit last month in U.S. ex rel. Zafirov v. Florida Medical Associates suggests that the court may affirm a lower court's opinion that the qui tam provisions of the False Claims Act are unconstitutional — which could wreak havoc on pending and future qui tam cases, say attorneys at Morgan Lewis.
-
Key Trends For Life Sciences Cos. To Watch In 2026
Following a year of drastic change at the U.S. Food and Drug Administration, two themes are likely to drive the coming year — a commitment to lowering the cost of drugs and an inherent tension between the priorities of the health agencies and the broader administration, say attorneys at Sheppard Mullin.
-
Series
Muay Thai Makes Me A Better Lawyer
Muay Thai kickboxing has taught me that in order to win, one must stick to one's game plan and adapt under pressure, just as when facing challenges by opposing counsel or judges, says Mark Schork at Feldman Shepherd.